Evidence map›Paper›PMID 30105738›Full record

ArticleDrug delivery and translational research2018

In situ gel-forming system for dual BMP-2 and 17β-estradiol controlled release for bone regeneration in osteoporotic rats.

Elisabet Segredo-Morales, Ricardo Reyes, María Rosa Arnau, Araceli Delgado, Carmen Évora

Abstract read
PubMed Publisher
In one paragraph

Article in Drug delivery and translational research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Elisabet Segredo-MoralesDepartment of Chemical Engineering and Pharmaceutical Technology, Universidad de La Laguna, 38200, La Laguna, Spain.
Ricardo ReyesDepartment of Biochemistry, Microbiology, Cell Biology and Genetics, Universidad de La Laguna, 38200, La Laguna, Spain.
María Rosa ArnauServicio de Estabulario, Universidad de La Laguna, 38200, La Laguna, Spain.
Araceli DelgadoDepartment of Chemical Engineering and Pharmaceutical Technology, Universidad de La Laguna, 38200, La Laguna, Spain.
Carmen ÉvoraDepartment of Chemical Engineering and Pharmaceutical Technology, Universidad de La Laguna, 38200, La Laguna, Spain. cevora@ull.es.
Universidad de La Laguna · ES

Funding

Ministerio de Economía y Competitividad MAT2014-55657-R
6 · The paper itself

Abstract

The aim of this study was to evaluate the bone regeneration capacity of a Pluronic® F127 (P)-Tetronic®1307 (T) and α-cyclodextrin (CD) supramolecular gel (P-T-CD) in a 11/7/7 ratio containing BMP-2 and 17β-estradiol pre-encapsulated in poly-lactide-co-glycolide (PLGA) and poly-lactic acid (PLA-S) microspheres, respectively. Ovariectomy combined with dexamethasone treatment was used to induce an osteoporotic (OP) animal model of calvaria critical size defect in female rats to test the system. The two active substances showed a biphasic in vitro release profile characterized by an initial fast phase followed by a slow and prolonged release. The bone morphogenetic protein-2 (BMP-2) in vivo release was faster than in vitro. The in vivo experimental design included four groups of sham rats and other four groups of OP rats treated with the blank system, BMP-2, and one or two doses of BMP-2 combined with 17β-estradiol. After 12 weeks, histological and histomorphometric analyses showed that the combined treatment with BMP-2 and 17β-estradiol did not improve the repair response in sham, whereas in OP animals, a significant increase in the repair rate was observed with respect to the group treated with BMP-2 alone. However, the low values of osteocalcin, showed an immature and poorly mineralized new bone in OP animals. The second dose of the system with BMP-2 and 17β-estradiol did not improve the repair response in any case.

Indexed as

AnimalsBone Morphogenetic Protein 2Bone RegenerationCapsulesDelayed-Action PreparationsDexamethasoneDisease Models, AnimalEstradiolFemaleHydrogelsOsteocalcinOsteoporosisOvariectomyRatsTreatment OutcomeBone Morphogenetic Protein 2CapsulesDelayed-Action PreparationsDexamethasoneEstradiolHydrogelsOsteocalcin17β-estradiolBMP-2Bone repairControlled releaseOsteoporosisSupramolecular gel

Identifiers

PMID30105738
OpenAlexW2886788733

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.